Tuesday, 18 November 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
November
(23)
- Calls for FDA overhaul
- Profit rise at Matthey
- RFCL-Mallinckrodt Baker deal delayed because of va...
- Three contracts for Eden
- Gedeon Richter has licensed DSM Biologics and Cruc...
- Dishman Pharma thinks it could see a 30% growth in...
- PacificGMP will manufacture Actinium's HuM195 mono...
- BASF to idle 80 plants reduce production in 100 more
- FDA opens China office
- Deretil in management buy-out
- Codexis licenses in enzyme technology
- BioReliance will produce investigational quantitie...
- Wacker Biotech has extended the licensing agreemen...
- Recipharm moves into biologics manufacturing
- BASF has acquired 94.55% of Ciba shares
- Jubilant Organosys has acquired TrialStat Clinical...
- Delays for Dishman
- DSM Pharmaceuticals will manufacture ATPace for Du...
- Daiichi Sankyo has completed its $4.5bn acquisitio...
- Germany's richest woman has offered $1.17bn for th...
- Cambrex expects market softening
- Lonza completes expansion
- Arsenal Capital has completed its acquisition of F...
-
▼
November
(23)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment